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Abstract 
An efficient approach to the stereoselective synthesis of a novel sulfur-bridged analogue of bosseopentaenoic 
acid (BPA) by employing the Z-selective modified Boland semi-reduction procedure as the key step is 
described. The free radical scavenging potential of the thiophene analogue of bosseopentaenoic acid is 
studied. The results showed that the thiophene ring led to increased antioxidant activity. 
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Introduction  
 
Polyunsaturated fatty acids (PUFAs) are a class of compounds, which have gained interest due to an array of 
beneficial health effects as dietary supplements.1-3 In physiological systems, ω-3 and ω-6 fatty acids, like 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid, are mostly esterified to the 
phospholipid cell membrane.  
Once PUFAs are released from the membrane they can participate in signal transduction, either directly or 
after enzymatic conversion to a variety of important, bioactive lipid mediators.4 In several studies the 
consumption of polyunsaturated fatty acids have shown positive health effects like reducing the risk of 
cardiovascular diseases5,6 and heart attack,7 positively associated with cognitive and behavioral 
performances4,5 as well as different types of cancer.6,7  
The promising biological effects as well as the complex chemical structures of the polyunsaturated fatty 
acids have made them interesting synthetic targets as well as lead compounds for medicinal chemists. Several 
attempts have been made to modify the PUFA structures, to improve or modify their biological activities, as 
well as to simplify the chemical synthesis. In 1985, Corey et al. substituted the methylene group at 7-position 
in arachidonic acid with sulfur.8 The resulting compound 1 possessed inhibitory activity for 5-lipoxygenase (5-
LO). Later, Hanko et al. synthesized and tested for 5-LO inhibition several analogues of arachidonic acid 
containing a sulfur atom at the 5-position.9 Structure–activity studies suggested the sulfur atom preferably 
should be attached to E-alkene as in compound 2 which was the most active 5-LO inhibitor of those tested in 
this study. In 2007, Skattebøl et al.10 reported the synthesis of several thiophene-containing PUFAs such as 
compounds 3 and 4 (Figure 1).  
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Figure 1. Chemical structures of biological active sulfur-containing PUFAs. 
 
From the aforementioned results, it is worth noting that the introduction of sulfur-bridged atom to 
polyunsaturated fatty acids (PUFAs) is an approach which has received great interest in enhancement of 
biological effects. Hence, we envisaged to synthesize a rigidified analogue of bosseopenteanoic acid 6a by 
replacement the two conjugated E,E-double bonds existed in bosseopentaenoic acid 5a to thiophene moiety 
and testing their antioxidant activity (Figure 2).  
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Figure 2. Chemical structure of bosseopentaenoic acid (BPA) 5a, the thiophene analogue of BPA 6a and the 
corresponding esters 5b and 6b. 
 
Bosseopentaenoic acid (BPA) 5a is a naturally occurring ω-6 fatty acid which containing four conjugated 
double bonds with Z,E,E,Z-configuration respectively and one skipped double bond with Z-configuration. The 
compound was isolated from the red alga Bossiella orbigniana by Burgess et al. in 1991,11 and the first total 
synthesis of methyl bosseopentaenoate 5b was published in 2011.12 Herein, we report a synthetic strategy 
towards a thiophene analogue of BPA 6a as well as its biological activity evaluation in comparison with BPA 5a.  
 
 
Results and Discussion  
 
Chemistry 
A retrosynthetic analysis of the polyunsaturated thiophene is outlined in Figure 3. The triyne 7 is the key 
intermediate in the synthesis of the target molecule 6a. The compound 7 can be converted to 6a by Z-
stereoselective semi-reduction of the three triple bonds to corresponding three cis-double bonds followed by 
hydrolysis of ester group to acid. In the described retrosynthetic pathway, the commercially available 2-
iodothiophene 11 was selected to be as starting material in the synthesis of thiophene analogue of 
bosseopentaenoic acid 6a (Figure 3). 
Our synthetic strategy started with the preparation of compound 13 from the reaction of 2-iodothiophene 
(15) with hept-1-yne (14) to produce compound 13 in 88% yield. This compound was reacted with lithium 
diisopropylamide (LDA) to form non-isolated intermediate 5-lithiothiophene13 13’ that was subsequently 
reacted with iodine to form 2-(hept-1-yn-1-yl)-5-iodothiophene (11) in 53% yield. A Sonogashira coupling14 
between compound 11 and propargyl alcohol 12 afforded compound 10 in 86% yield. Conversion of this 
alcohol 10 to corresponding bromide was performed using carbon tetrabromide and triphenyl phosphine at 
room temperature15,16 to obtain compound 8 in 77% yield. The 1H NMR analysis of compound 8 showed a 
singlet at δ 4.39 ppm, characteristic for CH2-Br. Triyne 7 was achieved in good yield (71%) through a skipped 
alkyne synthesis by coupling propargyl bromide 8 with methyl 5-hexynoate 9.17,18 A Z-stereoselective semi-
reduction of triyne 7, was carried out via a modified Boland protocol using Zn(Cu/Ag) in presence of 
trimethylsilyl chloride (TMSCl)19,20 at room temperature, to produce compound 6b in 65% yield. The modified 
Boland protocol, using Zn(Cu/Ag) in presence of TMSCl, proved to be important for this reaction12,20-23 
(Scheme 1); the same reduction carried out with a Lindlar catalyst resulted in a complex mixture of products.24 
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Figure 3. Retrosynthetic analysis of sulfur-bridged analogue of bosseopentaenoic acid 6a.  
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Scheme 1. Reagents and reaction conditions: a) Pd(Ph3P)2Cl2 (5 mol%) CuI (10 mol%), 1-heptyne (14), THF, 
room temperature; 3 h; b) LDA, I2, THF, -40 oC, 1 h; c) Pd(Ph3P)2Cl2 (5 mol%) CuI (10 mol%), propargyl alcohol 
(12), THF, room temperature, 3 h; d) CBr4, PPh3, CH2Cl2, room temperature, 2 h; e) Methyl hexynoate (9), Cul, 
n-Bu4NBr, Na2CO3, DMF, room temperature, 16 h; f) Zn(Cu/Ag), TMSCl, (MeOH: H2O, 1:1), room temperature, 
6 h. 
 
The hydrolysis of the methyl ester 6b using LiOH, provided the corresponding acid 6a in 62% isolated yield. 
An alternative milder and potentially higher yielding procedure for the hydrolysis of ester group existed in the 
sensitive substrate by the use of a lithium salt was considered.25 However, in our case the reaction did not 
proceed when the ester 6b was treated with 10 equivalents of LiI in THF/H2O (3:1) at room temperature for 
24 h. In addition, the use of triethylamine with LiI gave a low conversion to the carboxylic acid 6a. From these 
results, we decided to investigate a mild and more efficient procedure for the hydrolysis of the methyl ester of 
the thiophene analogue 6b, as well as methyl bosseopentaenoate 5b that was prepared according to the 
reported literature procedures.12 Herein, an in situ formation of LiI in a two-step reaction was carried out. The 
first step is the formation of TMSI by mixing TMSCl with KI. Then LiOH was added subsequently, to produce 
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lithium iodide (LiI) that mediated the hydrolysis of the methyl ester 6b under mild and efficient conditions to 
afford acid 6a after 6 hours in 87% isolated yield (Scheme 2).  
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Scheme 2. Reagents and reaction conditions: a) LiOH (6 eq), MeOH:H2O:THF (2:2:1), 4 h. b) TMSCl (3 eq), KI (3 
eq), LiOH (3 eq), MeOH:H2O:THF (2:1:1), 6 h. 
 
The correct configuration of the final compound was assigned by 1H NMR and 13C NMR data. The purity of 
the thiophene analogue 6b was determined by HPLC to be 99%. With this procedure, the hydrolysis of the 
ester group in methyl bosseopentaenoate 5b was executed. This method provided bosseopentaenoic acid 5a 
in 82% yield. The NMR data of BPA 5a were in good agreement with those previously reported.11 
 
Biological evaluation 
The free radical-scavenging potential of both BPA 5a and the thiophene analogue 6a was investigated in a 
DPPH scavenging assay in comparison with ascorbic acid as standard antioxidant agent. The thiophene 
analogue 6a exhibited good radical scavenging activity with SC50 5.74 µM. However, bosseopentaenoic acid 5a 
exhibited SC50 6.82 µM (Table 2).   
 
Table 2. Biological evaluation of the antioxidant activity of thiophene analogue using a DPPH radical 
scavenging method 
 
Compound 
Antioxidant activity 
DPPH radical scavenging 
SC50 (µM)a 
5a 6.82± 0.04 
6a 5.74 ± 0.05 
Ascorbic acid 9.34 ± 0.07 
a Results of three experiments performed in triplicate. 
 
Based on these results, both BPA and thiophene analogue have effect in scavenging superoxide. However, 
the thiophene analogue 6a has the higher susceptibility to oxidation more than BPA 5a dependent on the 
presence of sulfur-bridged atom in the structure that increased the stability of compound 6a.  
 
 
Conclusions 
 
An efficient stereoselective synthesis of a thiophene analogue of bosseopentaenoic acid 6a was achieved in 
12% yield over 7 steps, as well as antioxidant activity were evaluated. The the two E,E-double bonds in the 
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structure of bosseopentaenoic acid was replaced by thiophene moiety to act as a rigidified analogue of BPA. 
This replacement resulted in a less flexible structure with fewer rotational options. The key step in our 
synthetic approach was the Z-selective modified Boland-semi-reduction procedure to establish the three Z-
double bonds in one reaction. The biological evaluation revealed the thiophene analogue 6a exhibited an 
improved antioxidant activity compared to the lead bosseopentaenoic acid 5a. 
 
 
Experimental Section 
 
General. All reagents and solvents were used as purchased without further purification. Analytical TLC was 
performed on silica gel 60 F254 Aluminium sheets (Merck). Flash column chromatography was performed on 
silica gel 60 (40-60 μm, Fluka). NMR spectra were recorded on a Bruker Avance DPX spectrometer at 300 or at 
400 MHz for 1H NMR, 75 or 101 MHz for 13C NMR respectively. Coupling constants (J) are reported in hertz, 
and chemical shifts are reported in ppm (δ) relative to CDCl3 (7.24 ppm for 1H and 77.40 ppm for 13C). The 
HPLC analyses were performed using a Agilent Technologies 1200 Series with an Eclipse XD 8-C18 5 μm, 
4.6x150 mm column. High-resolution mass (ESI–MS) spectra were measured on (TOF) LC/MS; 6230 Series 
Accurate-Mass Time-of-Flight.  
 
2-(hept-1-yn-1-yl)thiophene (13). To a mixture of Pd(Ph3P)2Cl2 (0.33 g, 0.48 mmol, 5 mol%) and CuI (0.18 g, 
0.95 mmol, 10 mol%) in THF (5 mL) under nitrogen, piperidine (2.8 mL, 28.56 mmol, 3 eq) and 2-
iodothiophene (15) (2 g, 9.52 mmol, 1 eq) were added, followed by the addition of 1-heptyne (14) (0.91 g, 9.52 
mmol, 3 eq). The reaction mixture was allowed to stir for 3 h at room temperature. The resulting mixture was 
diluted with EtOAc (10 mL) then filtered through short pad of silica gel using EtOAc (30 mL) as eluent. The 
solution was washed with saturated ammonium chloride, dried (MgSO4) and evaporated under reduced 
pressure. The resulting crude product was purified by column chromatography (silica gel, hexane/EtOAc, 
90:10) to afford the title product as a colorless oil (1.49 g, 88%). 1H NMR (300 MHz, CDCl3): δ 7.20 (d, J 6.2 Hz, 
1H), 7.04-6.91 (m, 2H), 2.44 (t, J 7.1, 2H), 1.61-1.58 (m, 2H), 1.33-1.25 (m, 4H), 0.87 (t, J 8.6 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 132.6, 131.4, 126.0, 125.3, 122.6, 95.8, 97.1, 31.5, 29.8, 22.5, 14.3. HRMS calcd. for C11H15S 
[M+H]+ 179.0850, found [M+H]+ 179.0841.  
2-(hept-1-yn-1-yl)-5-iodothiophene (11). A solution of lithium diisopropylamide (LDA) (1.0 M in THF/hexane, 
0.71 mL, 7.09 mmol, 1.05 eq) in THF (20 mL) was cooled to -40 oC and 2-(hept-1-yn-1-yl)thiophene (13) (1.20 g, 
6.74 mmol, 1 eq) was added with stirring. After 10 min the mixture was warmed to -10 oC and stirred for 
approximately 10 min. The mixture was re-cooled to -40 oC and iodine (1.80 g, 7.09 mmol, 1.05 eq) was added 
in one portion. The reaction mixture was allowed to stir for 1 h and then it was warmed slowly to 0 oC and 
saturated NH4Cl solution (5 mL) was added. After extraction with Et2O, the combined extracts were dried with 
MgSO4 and the solvent was evaporated. The resulting crude product was purified by column chromatography 
(silica gel, hexane) to afford the title product as a colorless oil (1.08 mg, 53%).1H NMR (300 MHz, CDCl3): δ 7.05 
(d, J 3.8 Hz, 1H), 6.94 (d, J 3.8 Hz, 1H), 2.40 (t, J 7.1 Hz, 2H), 1.58-1.56 (m, 2H), 1.39-1.27 (m, 4H), 0.89 (t, J 7.1 
Hz, 3H).13C NMR (75 MHz, CDCl3): δ 132.5, 131.0, 126.4, 122.5, 96.3, 73.6, 31.5, 28.5, 22.5, 20.1, 14.3. HRMS 
calcd. for C11H14SI [M+H]+ 304.9860, found [M+H]+ 305.1094.  
3-(5-(Hept-1-yn-1-yl)thiophen-2-yl)prop-2-yn-1-ol (10). To a mixture of Pd(Ph3P)2Cl2 (103 mg, 0.17 mmol, 5 
mol%) and CuI (57 mg, 0.33 mmol, 10 mol%) in THF (5 mL) under nitrogen, piperidine (0.875 ml, 9.87 mmol, 3 
eq) and 2-(hept-1-yn-1-yl)-5-iodothiophene (11) (1.0 g, 3.29 mmol, 1 eq) were added, followed by the addition 
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of propargyl alcohol (12) (497 mg, 3.29 mmol, 1 eq). The reaction mixture was allowed to stir for 3 h at room 
temperature. The resulting mixture was diluted with EtOAc (10 mL) then filtered through short pad of silica gel 
using EtOAc (30 mL) as eluent. The solution was washed with saturated ammonium chloride, dried (MgSO4) 
and evaporated under reduced pressure. The resulting crude product was purified by column chromatography 
(silica gel, hexane/EtOAc, 90:10) to afford the title product as a colorless oil (1.5 g, 86%). 1H NMR (300 MHz, 
CDCl3): δ 7.01 (d, J 3.8 Hz, 1H), 6.89 (d, J 3.8 Hz, 1H), 4.49 (s, 2H), 2.42 (t, J 7.1 Hz, 2H), 1.59-1.56 (m, 2H), 1.44-
1.23 (m, 4H), 0.89 (t, J 7.1 Hz, 3H).13C NMR (75 MHz, CDCl3): δ 132.5, 131.1, 126.4, 122.5, 96.2, 91.6, 79.2, 73.6, 
52.1, 31.4, 28.5, 22.6, 20.1, 14.3. HRMS calcd. for C14H17OS [M+H]+ 233.1000, found [M+H]+ 233.0897.  
2-(3-bromoprop-1-yn-1-yl)-5-(hept-1-yn-1-yl)thiophene (8). To a stirred solution of 3-(5-(hept-1-yn-1-
yl)thiophen-2-yl)prop-2-yn-1-ol (10) (1 g, 4.31 mmol) and CBr4 (1.57 g, 4.74 mmol) in dichloromethane (30 mL) 
at 0 oC, Ph3P (1.36 g, 5.17 mmol) was added. The reaction mixture was stirred at room temperature for 3 h. 
The mixture was concentrated under vacuum to obtain a brown oil and quickly added to hexane with stirring 
(100 mL). The triphenylphosphine oxide (Ph3PO) was formed as a white precipitate and filtered off. The 
filtered solution was concentrated under reduced pressure using a rotary evaporator and then purified by 
flash column chromatography (silica gel, hexane) yielding compound 8 as colorless oil (0.98 g, 77%). 1H NMR 
(300 MHz, CDCl3): δ (ppm) 7.01 (s, 2H), 4.39 (s, 2H), 2.39 (t, J 7.4 Hz, 2H), 1.59-1.56 (m, 2H), 1.44-1.23 (m, 4H), 
0.89 (t, J 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 132.5, 131.0, 126.4, 122.5, 96.3, 91.6, 79.2, 73.6, 47.1, 31.5, 
28.5, 22.5, 20.0, 14.3. HRMS calcd. for C14H16BrS [M+H]+ 295.0156 found [M+H]+ 295.0152.  
Methyl-9-(5-(hept-1-yn-1-yl)thiophen-2-yl)nona-5,8-diynoate (7). To a mixture of Na2CO3 (0.36 g, 3.38 mmol, 
1.5 eq), CuI (0.43 g, 2.26 mmol, 1 eq), n-Bu4NBr (0.18 g, 0.68 mmol, 0.3 eq) in DMF (10 mL) at -20 oC, 5-methyl 
hexynoate (9) (0.28 g, 2.26 mmol, 1 eq) was added, followed by addition of propargyl bromide 8 (0.80 g, 2.71 
mmol, 1.2 eq). The reaction was allowed to stir at room temperature overnight. Et2O (5 mL) was added, and 
the resulted precipitate was filtered through a short pad of silica gel. Water (10 mL) was added to form an 
aqueous layer which was extracted with Et2O (3 x 25 mL). The organic layer was washed with saturated 
ammonium chloride and dried over MgSO4. The solvent was evaporated and the residue was purified by 
column chromatography (silica gel, hexane/EtOAc, 95:5). The title compound was isolated as colorless oil, 
which soon turned to yellow, in 71% yield (0.65 g). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.00 (s, 2H), 3.62 (s. 3H), 
2.95 (t, J 6.2 Hz, 2H), 2.42 (t, J 7.4 Hz, 2H), 2.38 (t, J 7.4 Hz, 2H), 2.31-2.13 (m, 2H), 1.69-1.26 (m, 6H), 1.58-1.56 
(m, 2H), 0.87 (t, J 7.4 Hz, 3H)). 13C NMR (75 MHz, CDCl3): 176.4, 132.8, 131.6, 130.4, 129.6, 129.3, 129.0, 128.9, 
128.7, 128.0, 126.8, 105.4, 100.8, 95.4, 85.2, 84.6, 80.0, 52.1, 33.2, 31.5, 28.5, 24.2, 22.5, 20.1, 18.6, 14.3, 
11.2. HRMS calcd. for C21H25O2S [M+H]+ 341.1475 found [M+H]+ 341.1542.  
Methyl-(5Z,8Z)-9-(5-((Z)-hept-1-en-1-yl)thiophen-2-yl)nona-5,8-dienoate (6b). For Z-selective semi-reduction 
of the triyne 7 we used the modified Boland procedure.12 The Zn(Cu/Ag) was prepared according to reported 
procedure in literature.19 To a suspension of the Zn(Cu/Ag) (2.0 g) in MeOH:H2O (1:1, 6 mL), the triyne 7 (0.40 
g, 0.08 mmol) was added and followed subsequently by the addition of trimethylsilyl chloride (TMSCl) (0.1 mL, 
0.80 mmol). The reaction mixture was stirred at ambient temperature for 6 h. Upon completion Et2O (5 mL) 
was added, the reaction mixture was filtered through a short plug of silica gel, and eluted with Et2O (3 x 5 mL). 
The combined organic phases were washed with saturated aqueous sodium chloride solution (10 mL), the 
organic layer was separated, dried (MgSO4), and then removal of the solvent afforded a residue that was 
purified by column chromatography (silica gel, hexane:EtOAc, 8:2, 7:3, 6:4, 1:1) to afford the desired triene 6b 
in 65% yield (0.26 g). 1H NMR (300 MHz, CDCl3): δ 7.05 (s, 2H), 6.11-5.95 (m, 2H), 5.46-5.27 (m, 4H), 3.65 (s, 
3H), 2.91 (t, J 6.2 Hz, 2H), 2.22 (t, J 7.4 Hz, 2H), 2.13-2.05 (m, 4H), 1.65 (p, J 7.4 Hz, 2H ), 1.23-1.20 (m, 6H), 0.86 
(t, J 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 174.0, 142.2, 139.4, 131.4, 129.6, 129.3, 129.0, 128.9, 125.2, 
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123.7, 122.1, 51.8, 33.8, 31.8, 29.7, 28.3, 26.9, 26.6, 25.1, 22.9, 14.4. HRMS calcd. for C21H31O2S [M+H]+ 
347.2045, found [M+H]+ 347.2187.  
(5Z,8Z)-9-(5-((Z)-hept-1-en-1-yl)thiophen-2-yl)nona-5,8-dienoic acid (6a)  
Procedure A. The methyl ester 6b (0.10 g, 0.29 mmol, 1 eq.) dissolved in THF (1 mL) was transferred to the 
reaction flask contained MeOH:H2O (2:1, 3 mL). Solid lithium hydroxide monohydrate (73 mg, 1.74 mmol, 6 
eq.) was added to the reaction mixture at 0 °C and it was stirred at 0 °C for 30 min., before the mixture was 
warmed to room temperature and it was allowed to stir for additional 3 h. The reaction mixture was acidified 
with saturated aq. NaH2PO4 (2 mL). EtOAc (5 mL) was added and the organic layer was separated. The aqueous 
layer was followed subsequently by extraction with EtOAc (2 × 5 mL). The combined organic layers were dried 
(MgSO4) and concentrated under vacuum. The crude product was purified by flash column chromatography 
(silica gel, hexane:EtOAc, 7:3, 6:4, 1:1, 3:7, 2:8) to afford thiophene analogue of bosseopentaenoic acid 6a in 
62% yield (59 mg).  
Procedure B. A solution of trimethylsilyl chloride (TMSCl) (0.11 g, 0.87 mmol, 3 eq), Potassium iodide (KI) (0.14 
g, 0.87 mmol, 3 eq) in MeOH:H2O (2:1, mL) was stirred at room temperature. After 15 min solid lithium 
hydroxide monohydrate (12 mg, 0.29 mmol, 3 eq) dissolved in H2O (1 mL) was added slowly, and the reaction 
mixture was stirred for additional 30 min. The methyl ester 6b (0.1 g, 0.29 mmol) dissolved in THF (1 mL) was 
added and the resulting mixture was stirred at ambient temperature for 6 h. Upon completion 1M Na2HPO4 (2 
mL) and EtOAc (2 mL) was added, and the organic layer was separated. The aqueous layer was further 
extracted with EtOAc (3 x 5 mL). The combined organic layers were dried (MgSO4) and concentrated under 
vacuum. The crude product was purified by flash column chromatography (silica gel, hexane:EtOAc, 7:3, 6:4, 
1:1, 3:7, 2:8) to obtain thiophene analogue of bosseopentaenoic acid 6a in 87% yield (83 mg). 1H NMR (300 
MHz, CDCl3): δ 12.51 (s, 1H), 7.02 (s, 2H), 6.02-5.97 (m, 2H), 5.48-5.30 (m, 4H), 2.89 (t, J 6.2 Hz), 2.16 (t, J 7.5 
Hz, 2H, 2.16 (t, J 7.5 Hz, 2H), 2.11-2.05 (m, 2H), 1.66 (p, J 7.5 Hz, 2H), 1.32-1.20 (m, 6H), 0.88 (t, J 6.8 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 180.1, 142.3, 139.4, 131.5 (2 x C), 129.7, 129.4, 129.1, 128.9, 123.3, 122.0, 33.8, 
31.9, 29.7, 28.3, 26.9, 26.6, 25.2, 22.9, 14.4. HRMS calcd. for C20H28O2S [M-H]+ 331.1732, found [M-H]+ 
331.1842. Purity (HPLC) 99%. 
Bosseopentaenoic acid (5a). A solution of TMSCl (31 mg, 0.29 mmol, 3 eq), KI (48 mg, 0.29 mmol, 3 eq) in 
MeOH:H2O (2:1, 3 mL) was allowed to stir at room temperature. After 15 min solid lithium hydroxide 
monohydrate (12 mg, 0.29 mmol, 3 eq) dissolved in H2O (1 mL) was added slowly, and the reaction mixture 
was stirred for additional 30 min. The methyl bosseopentaenoate 5b (30 mg, 0.096 mmol) dissolved in THF (1 
mL) was added and the resulting mixture was stirred at ambient temperature for 6 h. Upon completion 1M 
Na2HPO4 (2 mL) and EtOAc (2 mL) was added, and the organic layer was separated. The aqueous layer was 
further extracted with EtOAc (3 x 5 mL). The combined organic layers were dried (MgSO4) and concentrated 
under vacuum. The crude product was purified by flash column chromatography (silica gel, hexane: EtOAc, 
7:3, 6:4, 1:1, 3:7, 2:8) to obtain bosseopentaenoic acid 5a in 82% yield (24 mg). Spectroscopic and physical 
data were in agreement with those reported in the literature. 1H NMR (300 MHz, CDCl3): δ 6.49 (dd, J 13.4, 
10.8 Hz, 2H), 6.16-6.42 (m, 2H), 5.25-5.48 (m, 4H), 2.89 (t, J 7.4 Hz, 2H), 2.13 (q, J 7.4 Hz, 2H), 2.05 (t, J 7.4 Hz, 
2H), 1.54 (p, J 7.4 Hz, 2H), 1.21-1.91 (m, 6H), 0.88 (t, J 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 180.0, 133.6, 
133.0, 132.1, 129.9, 129.2, 129.0, 128.6, 128.4, 127.0, 126.5, 32.8, 31.3, 29.0, 27.9, 26.3, 26.2, 24.3, 22.6, 13.9. 
HRMS calcd. for C20H30O2 [M+Na]+ 325.2099, found [M+Na]+ 325.2038. Purity (HPLC) 98%. The NMR spectra 
was consistent with the published data.11  
Antioxidant activity DPPH scavenging assay 
To investigate the antioxidant activity an 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging assay was used. 
Various concentrations of the compounds (0.1-50 µg/mL) were prepared in MeOH. The solution (1.0 mL) was 
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added to 1.0 mL (0.2 mg/mL) methanol solution of DPPH and kept in dark. The decrease in absorbance at 517 
nm was observed after 30 min. The percentage scavenging of radical was determined and the results were 
expressed as the concentration of sample where absorbance of DPPH decreases 50% (SC50 values, µM). 26 
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